Diabetic ketoacidosis, or DKA, is one of the most feared complications of type 1 diabetes. That’s why researchers are looking for new and innovative ways to increase awareness of what DKA is and how it can be prevented.
Host Krista Lamb talks Dr. Bruce Perkins about his research to develop a tool to reduce the risk of DKA, as well as exciting new technologies in type 1 diabetes.
--------
21:35
Diabetes 360: Season 8, Episode 11
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
On this episode, host Krista Lamb is talking to Laura Syron, President and CEO of Diabetes Canada, about the many ways we can improve outcomes for people by rethinking how we talk about living with diabetes.
This is part two of a two-part series with Laura – if you haven’t heard part one, be sure to go back and listen to the episode before this one.
--------
17:41
Diabetes 360: Season 8, Episode 10
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
On this episode, host Krista Lamb is talking to Laura Syron, President and CEO of Diabetes Canada, about her journey with type 2 diabetes and the many ways we can improve outcomes for people by rethinking how we talk about living with this condition.
This is part one of a two-part series with Laura, so be sure to watch out for our next episode to hear the conclusion of the chat!
--------
20:18
Diabetes 360: Season 8, Episode 9
Many people are at risk for both diabetes and heart attacks. Millions of people take statin drugs to lower bad cholesterol and reduce the risk of heart attacks. But could these drugs also increase the risk for type 2 diabetes?
Host Krista Lamb talks to Dr. Jonathan Schertzer about his work on improving the safety and effectiveness of statins. Dr. Schertzer is an associate professor in Biochemistry and Biomedical Sciences at McMaster University, who holds a Canada Research Chair in Metabolic Inflammation. He is also the winner of Diabetes Canada’s 2023 Early Career Researcher Award.
--------
18:04
Diabetes 360: Season 8, Episode 8
As technology in type 1 diabetes becomes more advanced, we are starting to see an increase in personalized therapies. Whether someone is using hybrid closed loop or multiple daily injections, there are options being studied to make living with diabetes easier to manage.
On this episode, host Krista Lamb interviews Dr. Ahmad Haidar from McGill University about his research into diabetes technologies. Dr. Haidar is an Associate Professor in the Department of Biomedical Engineering who leads the McGill Diabetes Technologies Lab.
Canada - english